• (PLX AI) – Investors should buy Coloplast shares as the Atos Medical acquisition fits perfectly from both a business - and business-culture perspective, analysts at Kepler Cheuvreux said.
  • • Kepler previously rated Coloplast hold
  • • Price target raised to DKK 1,300 from DKK 1,150
  • • Coloplast is entering another high-growth market with Atos Medical, and the business integration from Q2 bridges the time until data from clinical studies and new launches, Kepler said
  • • Shares rose 2% today

Quelle: PLX AI